# Assessment of Safety Profile of MVA-BN Vaccine in the PALM-007 Study in DRC

> **NCT05734508** · PHASE4 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 500 (actual)

## Conditions studied

- Monkeypox

## Interventions

- **BIOLOGICAL:** MVA-BN vaccine

## Key facts

- **NCT ID:** NCT05734508
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-23
- **Primary completion:** 2024-06-28
- **Final completion:** 2024-06-28
- **Target enrollment:** 500 (ACTUAL)
- **Last updated:** 2026-02-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05734508

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05734508, "Assessment of Safety Profile of MVA-BN Vaccine in the PALM-007 Study in DRC". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05734508. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*